Skip to content
MedsAcross

Manufacturer

Melinta Therapeutics

Products listed
11
Molecules
6
Therapy areas
2

Melinta Therapeutics is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 11 of its products across 6 molecules, each with registers, packs and availability for export supply to licensed buyers.

Indian manufacturer
No
Also listed as
Melinta Therapeutics, LLC
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Melinta Therapeutics products through licensed channels, with the documents your regulator needs.

Antibiotics

6 presentations

Antibiotics overview
MedicineActive ingredientRegisterAvailability
Baxdela 300 mg/10.5 mL powder for injectionIntravenousDelafloxacinUS FDAAvailable on request
Baxdela 450 mg tabletOralDelafloxacinUS FDAAvailable on request
Kimyrsa 1200 mg/40 mL powder for injectionIntravenousOritavancinUS FDAAvailable on request
Minocin 100 mg injectionIntravenousMinocyclineUS FDAAvailable on request
Orbactiv 400 mg powder for injectionIntravenousOritavancinUS FDAAvailable on request
Vabomere 1 g/1 g per 2 g powder for injectionIntravenousMeropenem and VaborbactamUS FDAAvailable on request

Antifungals

1 presentation

Antifungals overview
MedicineActive ingredientRegisterAvailability
Rezzayo 200 mg powder for injectionIntravenousRezafunginUS FDAAvailable on request

Other products

4 presentations

MedicineActive ingredientRegisterAvailability
Toprol XL 100 mg extended-release tabletOralMetoprololUS FDAAvailable on request
Toprol XL 200 mg extended-release tabletOralMetoprololUS FDAAvailable on request
Toprol XL 25 mg extended-release tabletOralMetoprololUS FDAAvailable on request
Toprol XL 50 mg extended-release tabletOralMetoprololUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Melinta Therapeutics

Send a request for any of these products. We confirm the licensed source, documents and lead time.